HeartFlow Analysis vs eMurmur Heart AI
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive diagnostic assessment of coronary artery disease (CAD) based on standard CT scans. This tool is ideal for evaluating the functional significance of coronary stenoses using FFRct and characterizing plaque, providing detailed 3D models and computational fluid dynamics for precise treatment planning.
View HeartFlow Analysis →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if your primary need is automated, AI-powered analysis of heart and lung sounds for screening, monitoring, or remote consultation. This platform is well-suited for telehealth environments and general practice settings where rapid detection and classification of murmurs and other auscultatory findings are crucial for initial assessment and ongoing patient management.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | eMurmur Heart AI |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for quote |
| Deployment | Cloud-based (AWS) | Web-based, Mobile App, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers broader accessibility and flexibility with mobile apps, web portals, and hardware-neutral compatibility, making it suitable for diverse clinical settings including telehealth. HeartFlow Analysis, while integrated into radiology workflows, is more specialized in its deployment and user interaction.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis provides a non-invasive, highly accurate diagnostic solution for complex Coronary Artery Disease (CAD) using advanced AI-powered 3D modeling, FFRct analysis, and plaque quantification. This addresses a high-stakes diagnostic problem with significant impact on patient management.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis has a significant advantage due to established Category I CPT codes for FFRct Analysis (75580) and AI-Enabled Quantitative Plaque Analysis (75577 for 2026), with CMS payment rates already in place. This provides clear reimbursement pathways and recognized financial value for adopting institutions.
Enterprise Readiness
HeartFlow AnalysisBoth tools are cloud-based, HIPAA compliant, have BAAs, and are FDA cleared. However, HeartFlow is a 'commercial-stage' company with established reimbursement and integration support for PACS, EMR, and IT solutions, indicating a more mature and proven pathway for large-scale enterprise adoption.
Innovation
HeartFlow AnalysisHeartFlow Analysis demonstrates higher innovation through its sophisticated application of AI for 3D modeling of coronary arteries, computational fluid dynamics (CFD) for blood flow simulation, and FFRct analysis. This represents a more complex and advanced use of AI and computational science in healthcare.
Support & Docs
TieBoth HeartFlow and eMurmur, as commercial-stage medical technology companies, offer professional support and documentation resources on their respective websites. Without specific comparative details on the quality, breadth, or responsiveness of their support and documentation, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | eMurmur Heart AI |
|---|---|---|
| Company | HeartFlow | CSD Labs |
| Tagline | Decisive Coronary Care | Auscultation AI for healthier hearts & lungs. |
| Description | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmap™ Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole), Mobile app (iOS, Android) and web portal for access, Hardware-neutral and stethoscope agnostic platform compatibility, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring |
| Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and eMurmur Heart AI.